$AMRZ

Amrize Ltd

CIK:0002035989|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2026	Mar. 31, 2026	Jun. 30, 2025	Mar. 31, 2025	Jun. 30, 2026	Jun. 30, 2025	Dec. 31, 2025
Income Statement [Abstract]
Revenues	$ 3,494	$ 2,181	$ 3,218	$ 2,089	$ 5,675	$ 5,307
Cost of revenues	(2,501)	(1,973)	(2,277)	(1,852)	(4,474)	(4,129)
Gross profit	993	208	941	237	1,201	1,178
Selling, general and administrative expenses	(283)	(285)	(286)	(243)	(568)	(529)
Gain on disposal of long-lived assets	3	5	4	1	8	5
Loss on impairments	(2)		(2)		(2)	(2)
Operating income	711	(72)	657	(5)	639	652
Interest expense, net	(89)	(78)	(121)	(118)	(167)	(239)
Other non-operating income, net	(1)	2	1	1	1	2
Income before income tax expense and income from equity method investments	621	(148)	537	(122)	473	415
Income tax expense	(146)	41	(122)	28	(105)	(94)
Income from equity method investments	1		1		1	1
Net income	476	(107)	416	(94)	369	322	$ 1,191
Net loss attributable to noncontrolling interests	2	2	1	0	4	1
Net income attributable to the Company	$ 478	$ (105)	$ 417	$ (94)	$ 373	$ 323
Earnings per share attributable to the Company:
Basic (in dollars per share)	$ 0.87	$ (0.19)	$ 0.75	$ (0.17)	$ 0.67	$ 0.58
Diluted (in dollars per share)	$ 0.86	$ (0.19)	$ 0.75	$ (0.17)	$ 0.67	$ 0.58
Weighted-average number of shares outstanding:
Basic (in shares)	552.5	553.2	553.1	553.1	552.9	553.1
Diluted (in shares)	553.6	553.2	553.1	553.1	554.1	553.1

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2026	Mar. 31, 2026	Jun. 30, 2025	Mar. 31, 2025	Jun. 30, 2026	Jun. 30, 2025	Dec. 31, 2025
Cash Flows from Operating Activities:
Net income	$ 476	$ (107)	$ 416	$ (94)	$ 369	$ 322	$ 1,191
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation, depletion, accretion and amortization	257	237	226	220	494	444
Share-based compensation		9		1	20	3
Deferred tax benefit (expense)		(20)		6	27	(2)
Other items, net		26		35	72	54
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable, net		(209)		(287)	(939)	(827)
Due from related party		0		13	0	49
Inventories, net		3		(109)	(40)	(108)
Accounts payable		(510)		(213)	(186)	18
Due to related party		0		62	0	(96)
Other assets		(165)		(72)	(159)	(115)
Other liabilities		(150)		(403)	(121)	(170)
Defined benefit pension plans and other postretirement benefit plans		(7)		(6)	(12)	(13)
Net cash used in operating activities		(893)		(847)	(475)	(441)
Cash Flows from Investing Activities:
Purchases of property, plant and equipment		(275)		(213)	(520)	(448)
Acquisitions, net of cash acquired					(425)	(78)
Net decrease in short-term related-party notes receivable from cash pooling program					0	522
Other investing activities, net					49	(7)
Net cash used in investing activities		(662)		(62)	(896)	(11)
Cash Flows from Financing Activities:
Transfers to Holcim, net		0		(96)	0	(98)
Proceeds from short-term borrowings, net					735	930
Proceeds from issuance of long-term debt, net of discount					0	3,398
Payments of debt issuance costs					0	(24)
Net repayments of short-term related-party debt					0	(129)
Proceeds from debt-for-debt exchange with Holcim					0	922
Proceeds from issuances of long-term related-party debt					0	22
Repayments of long-term related-party debt					0	(5,541)
Payments of finance lease obligations					(64)	(48)
Repurchases of common stock					(178)	0
Dividends paid					(304)	0
Other financing activities, net					(1)	2
Net cash provided by (used in) financing activities		743		(104)	188	(566)
Effect of exchange rate changes on cash and cash equivalents					(10)	34
Decrease in cash and cash equivalents					(1,193)	(984)
Cash and cash equivalents at the beginning of period		$ 1,922		$ 1,585	1,922	1,585	1,585
Cash and cash equivalents at the end of period	$ 729		$ 601		$ 729	$ 601	$ 1,922

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2026	Mar. 31, 2026	Dec. 31, 2025	Jun. 30, 2025	Mar. 31, 2025	Dec. 31, 2024
Current Assets:
Cash and cash equivalents	$ 729		$ 1,922
Accounts receivable, net	2,057		1,113
Inventories, net	1,553		1,490
Prepaid expenses and other current assets	245		88
Total current assets	4,584		4,613
Property, plant and equipment, net	8,454		7,936
Goodwill	9,044		9,044
Intangible assets, net	1,682		1,728
Operating lease right-of-use assets, net	601		615
Other noncurrent assets	238		273
Total Assets	24,603		24,209
Current Liabilities:
Accounts payable	1,347		1,530
Short-term borrowings	735		0
Current portion of long-term debt	1,034		333
Operating lease liabilities	132		136
Other current liabilities	906		886
Total current liabilities	4,154		2,885
Long-term debt	4,235		4,936
Deferred income tax liabilities	1,146		1,042
Noncurrent operating lease liabilities	497		500
Other noncurrent liabilities	1,713		1,725
Total Liabilities	11,745		11,088
Commitments and contingencies (see Note 18)
Equity
Common stock, par value of $0.01 per share, 680,250,615 shares authorized, 566,875,513 issued and 549,779,621 outstanding as of June 30, 2026 566,875,513 issued and 553,082,525 outstanding as of December 31, 2025	6		6
Additional paid-in capital	12,590		12,569
Retained earnings	997		930
Treasury stock, 17,095,892 shares as of June 30, 2026 and 13,792,988 shares as of December 31, 2025	(194)		0
Accumulated other comprehensive loss	(533)		(380)
Total equity attributable to the Company	12,866		13,125
Noncontrolling interests	(8)		(4)
Total Equity	12,858	$ 12,966	13,121	$ 12,272	$ 9,607	$ 9,779
Total Liabilities and Equity	$ 24,603		$ 24,209